Many randomized clinical trials that lead to approvals for cancer drugs have suboptimal control arms, biasing outcomes in favor of the experimental arm.
Medscape Medical News
Clinical Trials of New Cancer Drugs ‘Frequently Flawed’
Many randomized clinical trials that lead to approvals for cancer drugs have suboptimal control arms, biasing outcomes in favor of the experimental arm.
Medscape Medical News
